, Volume 11, Issue 3, pp 189–196 | Cite as

Effectiveness of polymyxin B-direct hemoperfusion (PMX-DHP) therapy using a polymyxin B-immobilized fiber column in patients with post-esophagectomy sepsis

  • Masashi Takahashi
  • Hiroya TakeuchiEmail author
  • Hirofumi Kawakubo
  • Rieko Nakamura
  • Tsunehiro Takahashi
  • Norihito Wada
  • Yoshiro Saikawa
  • Tai Omori
  • Yuko Kitagawa
Original Article



Post-esophagectomy complications have an extremely poor prognosis. Recently, polymyxin B-direct hemoperfusion (PMX-DHP) therapy using a polymyxin B-immobilized fiber column was reported to be beneficial in gram-negative and/or gram-positive bacterial sepsis. The present retrospective study investigated the effectiveness and safety of PMX-DHP therapy in severe sepsis or septic shock after esophagectomy.


Fifteen severe sepsis or septic shock patients were included. Seven (four, pneumonia; two, anastomotic leakage; and one, reconstructed colon necrosis) patients received 2–5 h of PMX-DHP therapy (PMX-DHP therapy group), whereas 8 (three, pneumonia; three, anastomotic leakage; and two, gastric tube necrosis) received conventional therapy (control group).


Length of stay in the intensive care unit (ICU) was significantly shorter in the PMX-DHP therapy group than in the conventional therapy group (P = 0.040). In the comparison of pre- and post-PMX-DHP therapy groups, the total Sequential Organ Failure Assessment (SOFA) score, respiratory system score, and P/F ratio improved (P = 0.0027, P = 0.025, and P = 0.0087, respectively) in the post-PMX-DHP therapy group. In the comparison of conventional and PMX-DHP therapy groups, the variations in the total SOFA score, respiratory system score, and P/F ratio improved (P = 0.019, P = 0.0063, and P = 0.0015, respectively) in the PMX-DHP therapy group. Moreover, the respiratory system score was lower (P = 0.0062) in the PMX-DHP therapy group at the time of discharge from the ICU. No adverse effects were observed during the course of PMX-DHP therapy.


PMX-DHP therapy was safe and effective in improving respiratory and general conditions of patients with severe sepsis and septic shock after esophagectomy and decreased the length of stay in the ICU.


Esophagectomy Postoperative complications Sepsis Hemoperfusion 


Ethical Statement

This study was approved by the Ethics Committee of Keio University School of Medicine and was in accordance with the Helsinki Declaration of 1975, as revised in 2000 and 2008.

Conflict of interest

There are no financial or other relations that could lead to a conflict of interest.


  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Al-Sarira AA, David G, Willmott S, Slavin JP, Deakin M, Corless DJ. Oesophagectomy practice and outcomes in England. Br J Surg. 2007;94:585–91.PubMedCrossRefGoogle Scholar
  3. 3.
    Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990;77:845–57.PubMedCrossRefGoogle Scholar
  4. 4.
    Jamieson GG, Mathew G, Ludemann R, Wayman J, Myers JC, Devitt PG. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg. 2004;91:943–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg. 2007;245:232–40.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Atkins BZ, Shah AS, Hutcheson KA, Mangum JH, Pappas TN, Harpole DH Jr, D’Amico TA. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78:1170–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Ben-David K, Sarosi GA, Cendan JC, Howard D, Rossidis G, Hochwald SN. Decreasing morbidity and mortality in 100 consecutive minimally invasive esophagectomies. Surg Endosc. 2012;26:162–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Berrisford RG, Wajed SA, Sanders D, Rucklidge MW. Short-term outcomes following total minimally invasive oesophagectomy. Br J Surg. 2008;95:602–10.PubMedCrossRefGoogle Scholar
  9. 9.
    Zhang X, Watson DI, Jamieson GG, Lally C, Bessell JR, Devitt PG. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction. ANZ J Surg. 2005;75:513–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979–84.PubMedCrossRefGoogle Scholar
  11. 11.
    Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE. Pulmonary complications after esophagectomy. Ann Thorac Surg. 2002;73:922–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Fang W, Kato H, Tachimori Y, Igaki H, Sato H, Daiko H. Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer. Ann Thorac Surg. 2003;76:903–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Law S, Wong KH, Kwok KF, Chu KM, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791–800.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Nakamura M, Iwahashi M, Nakamori M, Ishida K, Naka T, Iida T, Katsuda M, Tsuji T, Nakatani Y, Yamaue H. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg. 2008;393:127–33.PubMedCrossRefGoogle Scholar
  15. 15.
    Shiozaki A, Fujiwara H, Okamura H, Murayama Y, Komatsu S, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Okamoto K, Ochiai T, Kokuba Y, Otsuji E. Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett. 2012;3:907–12.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Thompson AM, Rapson T, Gilbert FJ, Park KG. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg. 2007;94:578–84.PubMedCrossRefGoogle Scholar
  17. 17.
    Dhungel B, Diggs BS, Hunter JG, Sheppard BC, Vetto JT, Dolan JP. Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005–2008. J Gastrointest Surg. 2010;14:1492–501.PubMedCrossRefGoogle Scholar
  18. 18.
    Valenti V, Hernandez-Lizoain JL, Marinez-Regueira F, Bellver M, Rodriguez J, Diaz Gonzalez JA, Valenti V, Torres W, Sola JJ, Alvarez-Cienfuegos J. Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients: multidisciplinary approach. Clin Transl Oncol. 2011;13:899–903.PubMedCrossRefGoogle Scholar
  19. 19.
    Zingg U, Smithers BM, Gotley DC, Smith G, Aly A, Clough A, Esterman AJ, Jamieson GG, Watson DI. Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer. Ann Surg Oncol. 2011;18:1460–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Ferguson MK, Celauro AD, Prachand V. Prediction of major pulmonary complications after esophagectomy. Ann Thorac Surg. 2011;91:1494–500.PubMedCrossRefGoogle Scholar
  21. 21.
    Paul DJ, Jamieson GG, Watson DI, Devitt PG, Game PA. Perioperative risk analysis for acute respiratory distress syndrome after elective oesophagectomy. ANZ J Surg. 2011;81:700–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Bakhos CT, Fabian T, Oyasiji TO, Gautam S, Gangadharan SP, Kent MS, Martin J, Critchlow JF, De Camp MM. Impact of the surgical technique on pulmonary morbidity after esophagectomy. Ann Thorac Surg. 2012;93:221–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Rutegard M, Lagergren P, Rouvelas I, Lagergren J. Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study. Ann Surg Oncol. 2012;19:99–103.PubMedCrossRefGoogle Scholar
  24. 24.
    Turkyilmaz A, Eroglu A, Aydin Y, Muharrem Erol M, Karaoglanoglu N. The management of esophagogastric anastomotic leak after esophagectomy for esophageal carcinoma. Dis Esophagus. 2009;22:119–26.PubMedCrossRefGoogle Scholar
  25. 25.
    Cooke DT, Lin GC, Lau CL, Zhang L, Si MS, Lee J, Chang AC, Pickens A, Orringer MB. Analysis of cervical esophagogastric anastomotic leaks after transhiatal esophagectomy: risk factors, presentation, and detection. Ann Thorac Surg. 2009;88:177–84.PubMedCrossRefGoogle Scholar
  26. 26.
    Martin LW, Swisher SG, Hofstetter W, Correa AM, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg. 2005;242:392–9.PubMedCentralPubMedGoogle Scholar
  27. 27.
    Noble F, Curtis N, Harris S, Kelly JJ, Bailey IS, Byrne JP, Underwood TJ. Risk assessment using a novel score to predict anastomotic leak and major complications after oesophageal resection. J Gastrointest Surg. 2012;16:1083–95.PubMedCrossRefGoogle Scholar
  28. 28.
    Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, Ikeda T, Yagi Y, Takayama K, Amano I, Shimaoka H, Ohta M, Okahisa T, Koga N, Fujita N, Yamasa H. Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg. 2001;25:660–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Kushi H, Nakahara J, Miki T, Okamoto K, Saito T, Tanjo K. Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells. Ther Apher Dial. 2005;9:303–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Kushi H, Miki T, Nakahara J, Okamoto K, Saito T, Tanjoh K. Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase. Blood Purif. 2006;24:212–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Tsushima K, Kubo K, Koizumi T, Yamamoto H, Fujimoto K, Hora K, Kan-Nou Y. Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apher. 2002;17:97–102.PubMedCrossRefGoogle Scholar
  32. 32.
    Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care. 2005;9:R653–61.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Nakamura T, Kawagoe Y, Matsuda T, Shoji H, Ueda Y, Tamura N, Ebihara I, Koide H. Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients. Blood Purif. 2004;22:256–60.PubMedCrossRefGoogle Scholar
  34. 34.
    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest. 1992;101:1644–55.PubMedCrossRefGoogle Scholar
  35. 35.
    Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial. 2003;7:108–14.PubMedCrossRefGoogle Scholar
  36. 36.
    Routsi C, Pratikaki M, Sotiropoulou C, Platsouka E, Markaki V, Paniara O, Vincent JL, Roussoss C. Application of the sequential organ failure assessment (SOFA) score to bacteremic ICU patients. Infection. 2007;35:240–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S. The use of maximum sofa score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working group on sepsis related problems of the ESICM. Intensive Care Med. 1999;25:686–96.PubMedCrossRefGoogle Scholar
  38. 38.
    Sato K, Maekawa H, Sakurada M, Orita H, Komatsu Y. Direct hemoperfusion with polymyxin B immobilized fiber for abdominal sepsis in Europe. Surg Today. 2011;41:754–60.PubMedCrossRefGoogle Scholar
  39. 39.
    Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, Endo S. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial. 2006;10:12–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Sugimoto K, Sato K, Maekawa H, Sakurada M, Orita H, Ito T, Sakamoto K. Analysis of the efficacy of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) according to the prognostic factors in patients with colorectal perforation. Surg Today. 2013;43:1031–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.PubMedCrossRefGoogle Scholar
  42. 42.
    Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301:2445–52.PubMedCrossRefGoogle Scholar
  43. 43.
    Jaber BL, Barrett TW, Neto MC, Sundaram S, King AJ, Pereira BJ. Removal of cytokine inducing substances by polymyxin-B immobilized polystyrene-derivative fibers during in vitro hemoperfusion of 10% human plasma containing staphylococcus aureus challenge. ASAIO J. 1998;44:48–53.PubMedCrossRefGoogle Scholar
  44. 44.
    Yamamoto H, Koizumi T, Kaneki T, Fujimoto K, Kubo K, Honda T. Direct hemoperfusion with polymyxin B-immobilized fiber improves shock and hypoxemia during endotoxemia in anesthetized sheep. J Endotoxin Res. 2002;8:419–26.PubMedCrossRefGoogle Scholar
  45. 45.
    Kohro S, Imaizumi H, Yamakage M, Masuda Y, Namiki A, Asai Y, Maruyama I. Anandamide absorption by direct hemoperfusion with polymixin b-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. J Anesth. 2006;20:11–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Nakamura T, Ebihara I, Shoji H, Ushiyama C, Suzuki S, Koide H. Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble p-selectin, platelet factor 4 and beta-thromboglobulin. Inflamm Res. 1999;48:171–5.PubMedCrossRefGoogle Scholar
  47. 47.
    Sakamoto Y, Mashiko K, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients. ASAIO J. 2007;53:324–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Sakamoto Y, Mashiko K, Matsumoto H, Hara Y, Kutsukata N, Takei K, Ueno Y, Tomita Y, Yamamoto Y. Effect of direct hemoperfusion with a polymyxin B immobilized fiber column on high mobility group box-1 (HMGB-1) in severe septic shock: report of a case. ASAIO J. 2006;52:e37–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Suda K, Kitagawa Y, Ozawa S, Saikawa Y, Ueda M, Abraham E, Kitajima M, Ishizaka A. Serum concentrations of high-mobility group box chromosomal protein 1 before and after exposure to the surgical stress of thoracic esophagectomy: a predictor of clinical course after surgery? Dis Esophagus. 2006;19:5–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Takeda S, Munakata R, Abe S, Mii S, Suzuki M, Kashiwada T, Azuma A, Yamamoto T, Gemma A, Tanaka K. Hypercytokinemia with 2009 pandemic H1N1 (pH1N1) influenza successfully treated with polymyxin B-immobilized fiber column hemoperfusion. Intensive Care Med. 2010;36:906–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Totsugawa T, Kuinose M, Yoshitaka H, Tsushima Y, Ishida A, Chikazawa G, Katayama K, Hiraoka A. Intraoperative direct hemoperfusion with a polymyxin-B immobilized fiber column for treatment of infective endocarditis. Gen Thorac Cardiovasc Surg. 2011;59:98–104.PubMedCrossRefGoogle Scholar
  52. 52.
    Mitaka C, Tomita M. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock. Shock. 2011;36:332–8.PubMedCrossRefGoogle Scholar

Copyright information

© The Japan Esophageal Society and Springer Japan 2014

Authors and Affiliations

  • Masashi Takahashi
    • 1
  • Hiroya Takeuchi
    • 1
    Email author
  • Hirofumi Kawakubo
    • 1
  • Rieko Nakamura
    • 1
  • Tsunehiro Takahashi
    • 1
  • Norihito Wada
    • 1
  • Yoshiro Saikawa
    • 1
  • Tai Omori
    • 1
  • Yuko Kitagawa
    • 1
  1. 1.Department of SurgeryKeio University School of MedicineShinjuku-kuJapan

Personalised recommendations